Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hims & Hers Health Inc shares valued at $1,021,844 were sold by Chi Michael on Jun 17 ’25. At $59.75 per share, Chi Michael sold 17,102 shares. The insider’s holdings dropped to 278,654 shares worth approximately $17.02 million following the completion of this transaction.
Also, Dudum Andrew sold 128,127 shares, netting a total of over 7,271,950 in proceeds. Following the sale of shares at $56.76 each, the insider now holds 160,215 shares.
Before that, Dudum Andrew had sold 65,110 shares from its account. In a trade valued at $3,855,542, the Chief Executive Officer traded Hims & Hers Health Inc shares for $59.22 each. Upon closing the transaction, the insider’s holdings decreased to 65,110 shares, worth approximately $5.81 million.
As published in a research note from Needham on June 04, 2025, Hims & Hers Health Inc [HIMS] has been retained to a Buy and the price target has been revised to $65. Analysts at TD Cowen downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in late April. As of February 18, 2025, Morgan Stanley has decreased its “an Overweight” rating to a “an Equal-weight” for HIMS. Earlier on January 10, 2025, Citigroup downgraded its rating. Their new recommendation was “a Sell” for HIMS stock which previously was a “a Neutral”.
Analyzing HIMS Stock Performance
On last trading session,, Hims & Hers Health Inc [NYSE: HIMS] rose 3.09% to $61.07. During the last five days, there has been a surge of approximately 6.10%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 152.56%. Shares of the company reached a 52-week high of $72.98 on 02/19/25 and a 52-week low of $23.97 on 04/04/25.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 58.63, which, if violated, would cause prices to drop to 56.20. In the upper region, resistance lies at 63.02. The next price resistance is at 64.98. RSI (Relative Strength Index) is 62.71 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Hims & Hers Health Inc (HIMS)?
In terms of Hims & Hers Health Inc share price expectations, FactSet research, analysts set an average price target of 66.5 in the next 12 months, up nearly 12.26% from the previous closing price of $59.24. Analysts anticipate Hims & Hers Health Inc stock to reach 68 by 2025, with the lowest price target being 65. In spite of this, 13 analysts ranked Hims & Hers Health Inc stock as Buy at the end of 2025. On January 07, 2025, BTIG Research assigned a price target of “a Buy” to the stock and initiated coverage with a $35.
